nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—psoriasis—skin cancer	0.709	1	CtDrD
Acitretin—ALB—Vismodegib—skin cancer	0.0596	0.466	CbGbCtD
Acitretin—ALB—Vemurafenib—skin cancer	0.0471	0.368	CbGbCtD
Acitretin—ALB—Fluorouracil—skin cancer	0.0212	0.166	CbGbCtD
Acitretin—RBP1—hair follicle—skin cancer	0.00282	0.118	CbGeAlD
Acitretin—RXRG—neck—skin cancer	0.00171	0.0718	CbGeAlD
Acitretin—CYP26A1—female reproductive system—skin cancer	0.0016	0.0672	CbGeAlD
Acitretin—RARG—nipple—skin cancer	0.00144	0.0605	CbGeAlD
Acitretin—RBP1—epithelium—skin cancer	0.00129	0.054	CbGeAlD
Acitretin—RBP1—skin of body—skin cancer	0.00122	0.0514	CbGeAlD
Acitretin—RXRA—female reproductive system—skin cancer	0.000984	0.0413	CbGeAlD
Acitretin—RBP1—female reproductive system—skin cancer	0.000956	0.0401	CbGeAlD
Acitretin—RARG—skin of body—skin cancer	0.000924	0.0388	CbGeAlD
Acitretin—RARB—female reproductive system—skin cancer	0.000884	0.0371	CbGeAlD
Acitretin—RARG—mammalian vulva—skin cancer	0.000842	0.0354	CbGeAlD
Acitretin—RXRA—head—skin cancer	0.000822	0.0345	CbGeAlD
Acitretin—RBP1—head—skin cancer	0.000798	0.0335	CbGeAlD
Acitretin—RARB—head—skin cancer	0.000739	0.031	CbGeAlD
Acitretin—RXRG—head—skin cancer	0.000722	0.0303	CbGeAlD
Acitretin—RARG—female reproductive system—skin cancer	0.000721	0.0303	CbGeAlD
Acitretin—RARA—lymphoid tissue—skin cancer	0.000703	0.0295	CbGeAlD
Acitretin—RXRB—head—skin cancer	0.000679	0.0285	CbGeAlD
Acitretin—RARA—female reproductive system—skin cancer	0.000678	0.0285	CbGeAlD
Acitretin—RARG—head—skin cancer	0.000603	0.0253	CbGeAlD
Acitretin—RARA—head—skin cancer	0.000567	0.0238	CbGeAlD
Acitretin—RBP1—lymph node—skin cancer	0.000559	0.0235	CbGeAlD
Acitretin—RARB—lymph node—skin cancer	0.000517	0.0217	CbGeAlD
Acitretin—RARG—lymph node—skin cancer	0.000422	0.0177	CbGeAlD
Acitretin—RARA—lymph node—skin cancer	0.000397	0.0167	CbGeAlD
Acitretin—ALB—lymph node—skin cancer	0.000224	0.00939	CbGeAlD
Acitretin—CYP26A1—Adipogenesis—ASIP—skin cancer	0.000178	0.0943	CbGpPWpGaD
Acitretin—Insomnia—Imiquimod—skin cancer	0.000135	0.000984	CcSEcCtD
Acitretin—RXRG—Adipogenesis—ASIP—skin cancer	0.000135	0.0715	CbGpPWpGaD
Acitretin—Paraesthesia—Imiquimod—skin cancer	0.000134	0.000977	CcSEcCtD
Acitretin—Chills—Bleomycin—skin cancer	0.000134	0.000976	CcSEcCtD
Acitretin—Somnolence—Imiquimod—skin cancer	0.000133	0.000967	CcSEcCtD
Acitretin—Photosensitivity reaction—Fluorouracil—skin cancer	0.000132	0.000964	CcSEcCtD
Acitretin—Alopecia—Bleomycin—skin cancer	0.000132	0.000962	CcSEcCtD
Acitretin—Sinusitis—Temozolomide—skin cancer	0.000132	0.000959	CcSEcCtD
Acitretin—Dyspepsia—Imiquimod—skin cancer	0.000131	0.000958	CcSEcCtD
Acitretin—Erythema—Bleomycin—skin cancer	0.00013	0.000947	CcSEcCtD
Acitretin—Decreased appetite—Imiquimod—skin cancer	0.00013	0.000946	CcSEcCtD
Acitretin—Hot flush—Docetaxel—skin cancer	0.000129	0.000943	CcSEcCtD
Acitretin—Flushing—Dactinomycin—skin cancer	0.000129	0.000942	CcSEcCtD
Acitretin—Hypersensitivity—Vemurafenib—skin cancer	0.000129	0.00094	CcSEcCtD
Acitretin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000129	0.000939	CcSEcCtD
Acitretin—Fatigue—Imiquimod—skin cancer	0.000129	0.000938	CcSEcCtD
Acitretin—Menopausal symptoms—Docetaxel—skin cancer	0.000128	0.000935	CcSEcCtD
Acitretin—Visual disturbance—Docetaxel—skin cancer	0.000128	0.000931	CcSEcCtD
Acitretin—Pain—Imiquimod—skin cancer	0.000128	0.000931	CcSEcCtD
Acitretin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000127	0.000923	CcSEcCtD
Acitretin—RARA—Adipogenesis—ASIP—skin cancer	0.000127	0.0672	CbGpPWpGaD
Acitretin—Dermatitis bullous—Docetaxel—skin cancer	0.000127	0.000923	CcSEcCtD
Acitretin—Haemoglobin—Temozolomide—skin cancer	0.000127	0.000923	CcSEcCtD
Acitretin—Stomatitis—Fluorouracil—skin cancer	0.000126	0.000918	CcSEcCtD
Acitretin—Haemorrhage—Temozolomide—skin cancer	0.000126	0.000918	CcSEcCtD
Acitretin—Hepatitis—Temozolomide—skin cancer	0.000126	0.000918	CcSEcCtD
Acitretin—Conjunctivitis—Fluorouracil—skin cancer	0.000126	0.000916	CcSEcCtD
Acitretin—Urinary tract infection—Fluorouracil—skin cancer	0.000126	0.000916	CcSEcCtD
Acitretin—Asthenia—Vemurafenib—skin cancer	0.000126	0.000915	CcSEcCtD
Acitretin—Hypoaesthesia—Temozolomide—skin cancer	0.000125	0.000913	CcSEcCtD
Acitretin—Pharyngitis—Temozolomide—skin cancer	0.000125	0.000911	CcSEcCtD
Acitretin—Chills—Dactinomycin—skin cancer	0.000125	0.000911	CcSEcCtD
Acitretin—Oedema peripheral—Temozolomide—skin cancer	0.000124	0.000904	CcSEcCtD
Acitretin—Pruritus—Vemurafenib—skin cancer	0.000124	0.000903	CcSEcCtD
Acitretin—Alopecia—Dactinomycin—skin cancer	0.000123	0.000897	CcSEcCtD
Acitretin—Feeling abnormal—Imiquimod—skin cancer	0.000123	0.000897	CcSEcCtD
Acitretin—Gastrointestinal pain—Imiquimod—skin cancer	0.000122	0.00089	CcSEcCtD
Acitretin—Epistaxis—Fluorouracil—skin cancer	0.000122	0.000889	CcSEcCtD
Acitretin—Visual impairment—Temozolomide—skin cancer	0.000121	0.000885	CcSEcCtD
Acitretin—Sinusitis—Fluorouracil—skin cancer	0.000121	0.000884	CcSEcCtD
Acitretin—Erythema—Dactinomycin—skin cancer	0.000121	0.000883	CcSEcCtD
Acitretin—Ill-defined disorder—Bleomycin—skin cancer	0.000121	0.000879	CcSEcCtD
Acitretin—Diarrhoea—Vemurafenib—skin cancer	0.00012	0.000873	CcSEcCtD
Acitretin—Migraine—Docetaxel—skin cancer	0.000119	0.000868	CcSEcCtD
Acitretin—Urticaria—Imiquimod—skin cancer	0.000119	0.000864	CcSEcCtD
Acitretin—Abdominal pain—Imiquimod—skin cancer	0.000118	0.00086	CcSEcCtD
Acitretin—Body temperature increased—Imiquimod—skin cancer	0.000118	0.00086	CcSEcCtD
Acitretin—Eye disorder—Temozolomide—skin cancer	0.000118	0.000858	CcSEcCtD
Acitretin—Tinnitus—Temozolomide—skin cancer	0.000117	0.000856	CcSEcCtD
Acitretin—Malaise—Bleomycin—skin cancer	0.000117	0.000854	CcSEcCtD
Acitretin—Flushing—Temozolomide—skin cancer	0.000117	0.000852	CcSEcCtD
Acitretin—Haemoglobin—Fluorouracil—skin cancer	0.000117	0.00085	CcSEcCtD
Acitretin—Rhinitis—Fluorouracil—skin cancer	0.000116	0.000848	CcSEcCtD
Acitretin—Haemorrhage—Fluorouracil—skin cancer	0.000116	0.000846	CcSEcCtD
Acitretin—Dizziness—Vemurafenib—skin cancer	0.000116	0.000844	CcSEcCtD
Acitretin—Hypoaesthesia—Fluorouracil—skin cancer	0.000115	0.000841	CcSEcCtD
Acitretin—Pharyngitis—Fluorouracil—skin cancer	0.000115	0.000839	CcSEcCtD
Acitretin—Angiopathy—Temozolomide—skin cancer	0.000114	0.000833	CcSEcCtD
Acitretin—Immune system disorder—Temozolomide—skin cancer	0.000114	0.000829	CcSEcCtD
Acitretin—Cough—Bleomycin—skin cancer	0.000113	0.000827	CcSEcCtD
Acitretin—Chills—Temozolomide—skin cancer	0.000113	0.000824	CcSEcCtD
Acitretin—Ill-defined disorder—Dactinomycin—skin cancer	0.000112	0.00082	CcSEcCtD
Acitretin—Liver function test abnormal—Docetaxel—skin cancer	0.000112	0.000815	CcSEcCtD
Acitretin—Vomiting—Vemurafenib—skin cancer	0.000111	0.000811	CcSEcCtD
Acitretin—Alopecia—Temozolomide—skin cancer	0.000111	0.000811	CcSEcCtD
Acitretin—Dry skin—Docetaxel—skin cancer	0.000111	0.000809	CcSEcCtD
Acitretin—Chest pain—Bleomycin—skin cancer	0.000111	0.000806	CcSEcCtD
Acitretin—Myalgia—Bleomycin—skin cancer	0.000111	0.000806	CcSEcCtD
Acitretin—Rash—Vemurafenib—skin cancer	0.00011	0.000805	CcSEcCtD
Acitretin—Dermatitis—Vemurafenib—skin cancer	0.00011	0.000804	CcSEcCtD
Acitretin—Hypersensitivity—Imiquimod—skin cancer	0.00011	0.000802	CcSEcCtD
Acitretin—Headache—Vemurafenib—skin cancer	0.00011	0.000799	CcSEcCtD
Acitretin—Erythema—Temozolomide—skin cancer	0.00011	0.000799	CcSEcCtD
Acitretin—Discomfort—Bleomycin—skin cancer	0.000109	0.000797	CcSEcCtD
Acitretin—Malaise—Dactinomycin—skin cancer	0.000109	0.000797	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—PLIN2—skin cancer	0.000108	0.0572	CbGpPWpGaD
Acitretin—Dysgeusia—Temozolomide—skin cancer	0.000107	0.000782	CcSEcCtD
Acitretin—Asthenia—Imiquimod—skin cancer	0.000107	0.000781	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000107	0.000778	CcSEcCtD
Acitretin—Oedema—Bleomycin—skin cancer	0.000106	0.000773	CcSEcCtD
Acitretin—Back pain—Temozolomide—skin cancer	0.000106	0.000773	CcSEcCtD
Acitretin—Pruritus—Imiquimod—skin cancer	0.000106	0.00077	CcSEcCtD
Acitretin—Infection—Bleomycin—skin cancer	0.000105	0.000768	CcSEcCtD
Acitretin—Nausea—Vemurafenib—skin cancer	0.000104	0.000758	CcSEcCtD
Acitretin—Vision blurred—Temozolomide—skin cancer	0.000103	0.000753	CcSEcCtD
Acitretin—Myalgia—Dactinomycin—skin cancer	0.000103	0.000752	CcSEcCtD
Acitretin—Alopecia—Fluorouracil—skin cancer	0.000103	0.000747	CcSEcCtD
Acitretin—Diarrhoea—Imiquimod—skin cancer	0.000102	0.000745	CcSEcCtD
Acitretin—Discomfort—Dactinomycin—skin cancer	0.000102	0.000743	CcSEcCtD
Acitretin—Ill-defined disorder—Temozolomide—skin cancer	0.000102	0.000741	CcSEcCtD
Acitretin—Anorexia—Bleomycin—skin cancer	0.000101	0.000737	CcSEcCtD
Acitretin—Erythema—Fluorouracil—skin cancer	0.000101	0.000736	CcSEcCtD
Acitretin—Angioedema—Temozolomide—skin cancer	0.0001	0.00073	CcSEcCtD
Acitretin—Pancytopenia—Docetaxel—skin cancer	9.94e-05	0.000724	CcSEcCtD
Acitretin—Oedema—Dactinomycin—skin cancer	9.89e-05	0.000721	CcSEcCtD
Acitretin—Malaise—Temozolomide—skin cancer	9.89e-05	0.000721	CcSEcCtD
Acitretin—Dizziness—Imiquimod—skin cancer	9.87e-05	0.00072	CcSEcCtD
Acitretin—Infection—Dactinomycin—skin cancer	9.83e-05	0.000716	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Bleomycin—skin cancer	9.66e-05	0.000704	CcSEcCtD
Acitretin—Cough—Temozolomide—skin cancer	9.57e-05	0.000697	CcSEcCtD
Acitretin—Paraesthesia—Bleomycin—skin cancer	9.52e-05	0.000694	CcSEcCtD
Acitretin—Weight increased—Docetaxel—skin cancer	9.52e-05	0.000694	CcSEcCtD
Acitretin—Vision blurred—Fluorouracil—skin cancer	9.52e-05	0.000694	CcSEcCtD
Acitretin—Vomiting—Imiquimod—skin cancer	9.49e-05	0.000692	CcSEcCtD
Acitretin—Weight decreased—Docetaxel—skin cancer	9.47e-05	0.00069	CcSEcCtD
Acitretin—Anorexia—Dactinomycin—skin cancer	9.43e-05	0.000687	CcSEcCtD
Acitretin—Rash—Imiquimod—skin cancer	9.41e-05	0.000686	CcSEcCtD
Acitretin—Dermatitis—Imiquimod—skin cancer	9.4e-05	0.000685	CcSEcCtD
Acitretin—Headache—Imiquimod—skin cancer	9.35e-05	0.000682	CcSEcCtD
Acitretin—Myalgia—Temozolomide—skin cancer	9.33e-05	0.00068	CcSEcCtD
Acitretin—Arthralgia—Temozolomide—skin cancer	9.33e-05	0.00068	CcSEcCtD
Acitretin—Anxiety—Temozolomide—skin cancer	9.3e-05	0.000678	CcSEcCtD
Acitretin—Discomfort—Temozolomide—skin cancer	9.22e-05	0.000672	CcSEcCtD
Acitretin—Decreased appetite—Bleomycin—skin cancer	9.22e-05	0.000672	CcSEcCtD
Acitretin—Neuropathy peripheral—Docetaxel—skin cancer	9.14e-05	0.000667	CcSEcCtD
Acitretin—Dry mouth—Temozolomide—skin cancer	9.13e-05	0.000665	CcSEcCtD
Acitretin—Stomatitis—Docetaxel—skin cancer	9.09e-05	0.000663	CcSEcCtD
Acitretin—Jaundice—Docetaxel—skin cancer	9.09e-05	0.000663	CcSEcCtD
Acitretin—Pain—Bleomycin—skin cancer	9.07e-05	0.000661	CcSEcCtD
Acitretin—Conjunctivitis—Docetaxel—skin cancer	9.07e-05	0.000661	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Dactinomycin—skin cancer	9.01e-05	0.000657	CcSEcCtD
Acitretin—Oedema—Temozolomide—skin cancer	8.95e-05	0.000652	CcSEcCtD
Acitretin—Infection—Temozolomide—skin cancer	8.89e-05	0.000648	CcSEcCtD
Acitretin—Nausea—Imiquimod—skin cancer	8.87e-05	0.000646	CcSEcCtD
Acitretin—Epistaxis—Docetaxel—skin cancer	8.8e-05	0.000641	CcSEcCtD
Acitretin—Feeling abnormal—Bleomycin—skin cancer	8.74e-05	0.000637	CcSEcCtD
Acitretin—Skin disorder—Temozolomide—skin cancer	8.69e-05	0.000633	CcSEcCtD
Acitretin—Hyperhidrosis—Temozolomide—skin cancer	8.65e-05	0.00063	CcSEcCtD
Acitretin—Chest pain—Fluorouracil—skin cancer	8.6e-05	0.000627	CcSEcCtD
Acitretin—Myalgia—Fluorouracil—skin cancer	8.6e-05	0.000627	CcSEcCtD
Acitretin—Decreased appetite—Dactinomycin—skin cancer	8.6e-05	0.000627	CcSEcCtD
Acitretin—Fatigue—Dactinomycin—skin cancer	8.53e-05	0.000622	CcSEcCtD
Acitretin—Anorexia—Temozolomide—skin cancer	8.53e-05	0.000622	CcSEcCtD
Acitretin—Discomfort—Fluorouracil—skin cancer	8.5e-05	0.000619	CcSEcCtD
Acitretin—Pain—Dactinomycin—skin cancer	8.46e-05	0.000617	CcSEcCtD
Acitretin—Urticaria—Bleomycin—skin cancer	8.43e-05	0.000614	CcSEcCtD
Acitretin—Haemoglobin—Docetaxel—skin cancer	8.42e-05	0.000613	CcSEcCtD
Acitretin—Rhinitis—Docetaxel—skin cancer	8.4e-05	0.000612	CcSEcCtD
Acitretin—Body temperature increased—Bleomycin—skin cancer	8.38e-05	0.000611	CcSEcCtD
Acitretin—Hepatitis—Docetaxel—skin cancer	8.37e-05	0.00061	CcSEcCtD
Acitretin—Haemorrhage—Docetaxel—skin cancer	8.37e-05	0.00061	CcSEcCtD
Acitretin—Hypoaesthesia—Docetaxel—skin cancer	8.33e-05	0.000607	CcSEcCtD
Acitretin—Pharyngitis—Docetaxel—skin cancer	8.31e-05	0.000606	CcSEcCtD
Acitretin—Oedema peripheral—Docetaxel—skin cancer	8.25e-05	0.000601	CcSEcCtD
Acitretin—Oedema—Fluorouracil—skin cancer	8.24e-05	0.000601	CcSEcCtD
Acitretin—Infection—Fluorouracil—skin cancer	8.19e-05	0.000597	CcSEcCtD
Acitretin—RXRG—Adipogenesis—PLIN2—skin cancer	8.16e-05	0.0433	CbGpPWpGaD
Acitretin—Feeling abnormal—Dactinomycin—skin cancer	8.15e-05	0.000594	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Temozolomide—skin cancer	8.15e-05	0.000594	CcSEcCtD
Acitretin—Insomnia—Temozolomide—skin cancer	8.09e-05	0.00059	CcSEcCtD
Acitretin—Gastrointestinal pain—Dactinomycin—skin cancer	8.09e-05	0.00059	CcSEcCtD
Acitretin—Visual impairment—Docetaxel—skin cancer	8.07e-05	0.000588	CcSEcCtD
Acitretin—Paraesthesia—Temozolomide—skin cancer	8.03e-05	0.000586	CcSEcCtD
Acitretin—Somnolence—Temozolomide—skin cancer	7.95e-05	0.00058	CcSEcCtD
Acitretin—Dyspepsia—Temozolomide—skin cancer	7.88e-05	0.000574	CcSEcCtD
Acitretin—Anorexia—Fluorouracil—skin cancer	7.86e-05	0.000573	CcSEcCtD
Acitretin—Eye disorder—Docetaxel—skin cancer	7.83e-05	0.00057	CcSEcCtD
Acitretin—Abdominal pain—Dactinomycin—skin cancer	7.82e-05	0.00057	CcSEcCtD
Acitretin—Body temperature increased—Dactinomycin—skin cancer	7.82e-05	0.00057	CcSEcCtD
Acitretin—Hypersensitivity—Bleomycin—skin cancer	7.81e-05	0.00057	CcSEcCtD
Acitretin—Decreased appetite—Temozolomide—skin cancer	7.78e-05	0.000567	CcSEcCtD
Acitretin—Flushing—Docetaxel—skin cancer	7.77e-05	0.000566	CcSEcCtD
Acitretin—Gastrointestinal disorder—Temozolomide—skin cancer	7.72e-05	0.000563	CcSEcCtD
Acitretin—Fatigue—Temozolomide—skin cancer	7.71e-05	0.000562	CcSEcCtD
Acitretin—RARA—Adipogenesis—PLIN2—skin cancer	7.67e-05	0.0407	CbGpPWpGaD
Acitretin—Constipation—Temozolomide—skin cancer	7.65e-05	0.000558	CcSEcCtD
Acitretin—Pain—Temozolomide—skin cancer	7.65e-05	0.000558	CcSEcCtD
Acitretin—Asthenia—Bleomycin—skin cancer	7.61e-05	0.000555	CcSEcCtD
Acitretin—Angiopathy—Docetaxel—skin cancer	7.6e-05	0.000554	CcSEcCtD
Acitretin—Immune system disorder—Docetaxel—skin cancer	7.56e-05	0.000551	CcSEcCtD
Acitretin—Chills—Docetaxel—skin cancer	7.51e-05	0.000548	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Fluorouracil—skin cancer	7.51e-05	0.000547	CcSEcCtD
Acitretin—Pruritus—Bleomycin—skin cancer	7.5e-05	0.000547	CcSEcCtD
Acitretin—Insomnia—Fluorouracil—skin cancer	7.46e-05	0.000543	CcSEcCtD
Acitretin—Paraesthesia—Fluorouracil—skin cancer	7.4e-05	0.00054	CcSEcCtD
Acitretin—Alopecia—Docetaxel—skin cancer	7.4e-05	0.000539	CcSEcCtD
Acitretin—Feeling abnormal—Temozolomide—skin cancer	7.37e-05	0.000537	CcSEcCtD
Acitretin—Somnolence—Fluorouracil—skin cancer	7.33e-05	0.000534	CcSEcCtD
Acitretin—Gastrointestinal pain—Temozolomide—skin cancer	7.32e-05	0.000533	CcSEcCtD
Acitretin—Erythema—Docetaxel—skin cancer	7.29e-05	0.000531	CcSEcCtD
Acitretin—Hypersensitivity—Dactinomycin—skin cancer	7.29e-05	0.000531	CcSEcCtD
Acitretin—Dyspepsia—Fluorouracil—skin cancer	7.26e-05	0.000529	CcSEcCtD
Acitretin—Decreased appetite—Fluorouracil—skin cancer	7.17e-05	0.000522	CcSEcCtD
Acitretin—Dysgeusia—Docetaxel—skin cancer	7.14e-05	0.00052	CcSEcCtD
Acitretin—Gastrointestinal disorder—Fluorouracil—skin cancer	7.12e-05	0.000519	CcSEcCtD
Acitretin—Urticaria—Temozolomide—skin cancer	7.11e-05	0.000518	CcSEcCtD
Acitretin—Asthenia—Dactinomycin—skin cancer	7.1e-05	0.000517	CcSEcCtD
Acitretin—Abdominal pain—Temozolomide—skin cancer	7.07e-05	0.000515	CcSEcCtD
Acitretin—Body temperature increased—Temozolomide—skin cancer	7.07e-05	0.000515	CcSEcCtD
Acitretin—Back pain—Docetaxel—skin cancer	7.05e-05	0.000514	CcSEcCtD
Acitretin—Pain—Fluorouracil—skin cancer	7.05e-05	0.000514	CcSEcCtD
Acitretin—Muscle spasms—Docetaxel—skin cancer	7.01e-05	0.000511	CcSEcCtD
Acitretin—Feeling abnormal—Fluorouracil—skin cancer	6.79e-05	0.000495	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—skin cancer	6.77e-05	0.000493	CcSEcCtD
Acitretin—Vomiting—Bleomycin—skin cancer	6.74e-05	0.000492	CcSEcCtD
Acitretin—Rash—Bleomycin—skin cancer	6.69e-05	0.000487	CcSEcCtD
Acitretin—Dermatitis—Bleomycin—skin cancer	6.68e-05	0.000487	CcSEcCtD
Acitretin—RXRA—Adipogenesis—ASIP—skin cancer	6.6e-05	0.035	CbGpPWpGaD
Acitretin—Hypersensitivity—Temozolomide—skin cancer	6.59e-05	0.00048	CcSEcCtD
Acitretin—Urticaria—Fluorouracil—skin cancer	6.55e-05	0.000477	CcSEcCtD
Acitretin—Body temperature increased—Fluorouracil—skin cancer	6.52e-05	0.000475	CcSEcCtD
Acitretin—Asthenia—Temozolomide—skin cancer	6.42e-05	0.000468	CcSEcCtD
Acitretin—Cough—Docetaxel—skin cancer	6.36e-05	0.000464	CcSEcCtD
Acitretin—Pruritus—Temozolomide—skin cancer	6.33e-05	0.000461	CcSEcCtD
Acitretin—Nausea—Bleomycin—skin cancer	6.3e-05	0.000459	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—skin cancer	6.29e-05	0.000458	CcSEcCtD
Acitretin—Rash—Dactinomycin—skin cancer	6.24e-05	0.000455	CcSEcCtD
Acitretin—Arthralgia—Docetaxel—skin cancer	6.21e-05	0.000452	CcSEcCtD
Acitretin—Chest pain—Docetaxel—skin cancer	6.21e-05	0.000452	CcSEcCtD
Acitretin—Myalgia—Docetaxel—skin cancer	6.21e-05	0.000452	CcSEcCtD
Acitretin—Diarrhoea—Temozolomide—skin cancer	6.12e-05	0.000446	CcSEcCtD
Acitretin—Hypersensitivity—Fluorouracil—skin cancer	6.07e-05	0.000443	CcSEcCtD
Acitretin—Dry mouth—Docetaxel—skin cancer	6.07e-05	0.000442	CcSEcCtD
Acitretin—Oedema—Docetaxel—skin cancer	5.95e-05	0.000434	CcSEcCtD
Acitretin—Dizziness—Temozolomide—skin cancer	5.92e-05	0.000431	CcSEcCtD
Acitretin—Infection—Docetaxel—skin cancer	5.91e-05	0.000431	CcSEcCtD
Acitretin—Nausea—Dactinomycin—skin cancer	5.88e-05	0.000428	CcSEcCtD
Acitretin—Pruritus—Fluorouracil—skin cancer	5.83e-05	0.000425	CcSEcCtD
Acitretin—Skin disorder—Docetaxel—skin cancer	5.78e-05	0.000421	CcSEcCtD
Acitretin—Vomiting—Temozolomide—skin cancer	5.69e-05	0.000415	CcSEcCtD
Acitretin—Anorexia—Docetaxel—skin cancer	5.67e-05	0.000413	CcSEcCtD
Acitretin—Rash—Temozolomide—skin cancer	5.64e-05	0.000411	CcSEcCtD
Acitretin—Diarrhoea—Fluorouracil—skin cancer	5.64e-05	0.000411	CcSEcCtD
Acitretin—Dermatitis—Temozolomide—skin cancer	5.64e-05	0.000411	CcSEcCtD
Acitretin—Headache—Temozolomide—skin cancer	5.6e-05	0.000409	CcSEcCtD
Acitretin—Dizziness—Fluorouracil—skin cancer	5.45e-05	0.000397	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Docetaxel—skin cancer	5.42e-05	0.000395	CcSEcCtD
Acitretin—Insomnia—Docetaxel—skin cancer	5.38e-05	0.000392	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—skin cancer	5.34e-05	0.000389	CcSEcCtD
Acitretin—Nausea—Temozolomide—skin cancer	5.31e-05	0.000387	CcSEcCtD
Acitretin—Somnolence—Docetaxel—skin cancer	5.29e-05	0.000386	CcSEcCtD
Acitretin—Vomiting—Fluorouracil—skin cancer	5.24e-05	0.000382	CcSEcCtD
Acitretin—Dyspepsia—Docetaxel—skin cancer	5.24e-05	0.000382	CcSEcCtD
Acitretin—Rash—Fluorouracil—skin cancer	5.2e-05	0.000379	CcSEcCtD
Acitretin—Dermatitis—Fluorouracil—skin cancer	5.19e-05	0.000378	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—skin cancer	5.17e-05	0.000377	CcSEcCtD
Acitretin—Headache—Fluorouracil—skin cancer	5.16e-05	0.000376	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—skin cancer	5.14e-05	0.000374	CcSEcCtD
Acitretin—Fatigue—Docetaxel—skin cancer	5.13e-05	0.000374	CcSEcCtD
Acitretin—Pain—Docetaxel—skin cancer	5.09e-05	0.000371	CcSEcCtD
Acitretin—Constipation—Docetaxel—skin cancer	5.09e-05	0.000371	CcSEcCtD
Acitretin—Feeling abnormal—Docetaxel—skin cancer	4.9e-05	0.000357	CcSEcCtD
Acitretin—Nausea—Fluorouracil—skin cancer	4.9e-05	0.000357	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—skin cancer	4.87e-05	0.000355	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	4.86e-05	0.0258	CbGpPWpGaD
Acitretin—Body temperature increased—Docetaxel—skin cancer	4.7e-05	0.000343	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—skin cancer	4.7e-05	0.000343	CcSEcCtD
Acitretin—RXRA—PPARA activates gene expression—PLIN2—skin cancer	4.57e-05	0.0243	CbGpPWpGaD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	4.47e-05	0.0237	CbGpPWpGaD
Acitretin—Hypersensitivity—Docetaxel—skin cancer	4.38e-05	0.00032	CcSEcCtD
Acitretin—Asthenia—Docetaxel—skin cancer	4.27e-05	0.000311	CcSEcCtD
Acitretin—Pruritus—Docetaxel—skin cancer	4.21e-05	0.000307	CcSEcCtD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	4.11e-05	0.0218	CbGpPWpGaD
Acitretin—Diarrhoea—Docetaxel—skin cancer	4.07e-05	0.000297	CcSEcCtD
Acitretin—RXRA—Adipogenesis—PLIN2—skin cancer	4e-05	0.0212	CbGpPWpGaD
Acitretin—Dizziness—Docetaxel—skin cancer	3.93e-05	0.000287	CcSEcCtD
Acitretin—RXRA—PPAR Alpha Pathway—CDK4—skin cancer	3.87e-05	0.0205	CbGpPWpGaD
Acitretin—Vomiting—Docetaxel—skin cancer	3.78e-05	0.000276	CcSEcCtD
Acitretin—Rash—Docetaxel—skin cancer	3.75e-05	0.000273	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—skin cancer	3.75e-05	0.000273	CcSEcCtD
Acitretin—Headache—Docetaxel—skin cancer	3.73e-05	0.000272	CcSEcCtD
Acitretin—Nausea—Docetaxel—skin cancer	3.53e-05	0.000258	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—RHOU—skin cancer	3.29e-05	0.0175	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.22e-05	0.0171	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.09e-05	0.0164	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	3.08e-05	0.0164	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	3.06e-05	0.0162	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.93e-05	0.0155	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	2.07e-05	0.011	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—skin cancer	2.07e-05	0.011	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	1.95e-05	0.0103	CbGpPWpGaD
Acitretin—RBP1—Disease—CSPG4—skin cancer	1.74e-05	0.00922	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—IL6—skin cancer	1.72e-05	0.00914	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	1.62e-05	0.00862	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	1.61e-05	0.00855	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTCH2—skin cancer	1.61e-05	0.00852	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.57e-05	0.00834	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.53e-05	0.0081	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.51e-05	0.00799	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PLIN2—skin cancer	1.47e-05	0.00781	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SCN10A—skin cancer	1.3e-05	0.00692	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.23e-05	0.00651	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GLI2—skin cancer	1.22e-05	0.00646	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CSPG4—skin cancer	1.19e-05	0.0063	CbGpPWpGaD
Acitretin—RBP1—Disease—SHH—skin cancer	1.18e-05	0.00627	CbGpPWpGaD
Acitretin—RBP1—Disease—ENO2—skin cancer	1.18e-05	0.00627	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MC1R—skin cancer	1.16e-05	0.00616	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GLI1—skin cancer	1.14e-05	0.00607	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.12e-05	0.00596	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—IL6—skin cancer	1.12e-05	0.00594	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.11e-05	0.00587	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SUFU—skin cancer	1.09e-05	0.00576	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.08e-05	0.00571	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—skin cancer	1.02e-05	0.00539	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	9.93e-06	0.00527	CbGpPWpGaD
Acitretin—RBP1—Disease—FOXO4—skin cancer	9.63e-06	0.00511	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—IL6—skin cancer	8.49e-06	0.0045	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SHH—skin cancer	8.28e-06	0.00439	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RASA1—skin cancer	8.22e-06	0.00436	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ENO2—skin cancer	8.07e-06	0.00428	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—IL6—skin cancer	7.98e-06	0.00423	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	7.85e-06	0.00417	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SMO—skin cancer	7.84e-06	0.00416	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTCH1—skin cancer	7.84e-06	0.00416	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTGER4—skin cancer	7.64e-06	0.00405	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.52e-06	0.00399	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RASA1—skin cancer	7.49e-06	0.00397	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.21e-06	0.00383	CbGpPWpGaD
Acitretin—RBP1—Disease—ERCC2—skin cancer	6.86e-06	0.00364	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FOXO4—skin cancer	6.75e-06	0.00358	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.68e-06	0.00355	CbGpPWpGaD
Acitretin—RBP1—Disease—TERT—skin cancer	6.43e-06	0.00341	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.41e-06	0.0034	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	5.61e-06	0.00298	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.6e-06	0.00297	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLIN2—skin cancer	5.47e-06	0.0029	CbGpPWpGaD
Acitretin—RBP1—Disease—BRAF—skin cancer	5.1e-06	0.0027	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.05e-06	0.00268	CbGpPWpGaD
Acitretin—RARG—Gene Expression—ERCC2—skin cancer	4.99e-06	0.00265	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	4.76e-06	0.00252	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ERCC2—skin cancer	4.69e-06	0.00249	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—ERCC2—skin cancer	4.57e-06	0.00242	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TERT—skin cancer	4.51e-06	0.00239	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ERCC2—skin cancer	4.48e-06	0.00238	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CSPG4—skin cancer	4.41e-06	0.00234	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ERCC2—skin cancer	4.29e-06	0.00228	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ERCC2—skin cancer	4.29e-06	0.00228	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—IL6—skin cancer	4.16e-06	0.00221	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—skin cancer	4.12e-06	0.00218	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IL6—skin cancer	4.01e-06	0.00213	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.76e-06	0.00199	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CDK4—skin cancer	3.67e-06	0.00195	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—skin cancer	3.57e-06	0.00189	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—skin cancer	3.56e-06	0.00189	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	3.34e-06	0.00177	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—skin cancer	3.26e-06	0.00173	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—skin cancer	3.2e-06	0.0017	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—skin cancer	3e-06	0.00159	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—skin cancer	2.81e-06	0.00149	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—skin cancer	2.76e-06	0.00146	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—skin cancer	2.59e-06	0.00138	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLIN2—skin cancer	2.49e-06	0.00132	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.34e-06	0.00124	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—skin cancer	2.34e-06	0.00124	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—skin cancer	2.24e-06	0.00119	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—skin cancer	2.24e-06	0.00119	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ERCC2—skin cancer	2.24e-06	0.00119	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—skin cancer	2.04e-06	0.00108	CbGpPWpGaD
Acitretin—ALB—Metabolism—CSPG4—skin cancer	2.01e-06	0.00107	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—skin cancer	1.93e-06	0.00102	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—skin cancer	1.76e-06	0.000932	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ERCC2—skin cancer	1.74e-06	0.000923	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—skin cancer	1.72e-06	0.00091	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—skin cancer	1.64e-06	0.000871	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—skin cancer	1.57e-06	0.000833	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—skin cancer	1.49e-06	0.000792	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—skin cancer	1.43e-06	0.000758	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—skin cancer	1.37e-06	0.000725	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.07e-06	0.000567	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—skin cancer	1.04e-06	0.000554	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—skin cancer	9.13e-07	0.000485	CbGpPWpGaD
Acitretin—ALB—Metabolism—ERCC2—skin cancer	7.94e-07	0.000421	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—skin cancer	7.86e-07	0.000417	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—skin cancer	6.99e-07	0.000371	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—skin cancer	6.68e-07	0.000355	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—skin cancer	4.76e-07	0.000253	CbGpPWpGaD
